Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Will Chart Analysts Notice Bad Omen on Sirius XM Holdings's Chart

If history is any guide, there may be trouble ahead for shares of Sirius XM Holdings (NASDAQ:SIRI). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Thursday Is Your Last Chance To Buy CDK Global Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from CDK Global (NASDAQ:CDK).

Benzinga

Why Kaival Brands Stock Is Soaring

Kaival Brands Innovations Group Inc (NASDAQ: KAVL) shares are trading significantly higher Tuesday after the company reached an agreement with Phillip Morris for international electronic nicotine delivery system product development and distribution.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Thursday Is Your Last Chance To Buy Creative Media Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Creative Media (NASDAQ:CMCT).

Benzinga

Nathan's Famous: Dividend Insights

Thursday marks the last chance for investors to receive the next dividend payout from Nathan's Famous (NASDAQ:NATH).

Benzinga

5 Value Stocks In The Technology Sector

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 15 Years

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 15 years by 12.08% on an annualized basis producing an average annual return of 18.33%. Currently, Intuitive Surgical has a market capitalization of $69.16 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Exscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy Volunteers

Exscientia plc (NASDAQ:EXAI) announced data from its Phase 1 healthy volunteer study of EXS-21546, its highly selective A2A receptor antagonist. The drug candidate is co-invented and developed through a collaboration between Exscientia and Evotec SE (NASDAQ:EVO). Topline data confirmed Exscientia’s target product profile design, including potency, high receptor selectivity, and expected low brain exposure with…

Benzinga

Why Coinbase Stock Is Sliding Today

Coinbase Global Inc (NASDAQ: COIN) shares are trading lower Tuesday after the company announced a restructuring plan.

Benzinga

Mid-Morning Market Update: Markets Open Higher; US Producer Prices Increase 0.8% In May

U.S. stocks traded higher this morning, with the Dow Jones gaining by more than 100 points on Tuesday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

Upgrades

Benzinga

$1000 Invested In Intuit 5 Years Ago Would Be Worth This Much Today

Intuit (NASDAQ:INTU) has outperformed the market over the past 5 years by 11.98% on an annualized basis producing an average annual return of 20.88%. Currently, Intuit has a market capitalization of $102.61 billion.

Benzinga

Looking Into First Advantage's Return On Capital Employed

Pulled from Benzinga Pro data, First Advantage (NASDAQ:FA) posted Q1 earnings of $13.01 million, an increase from Q4 of 15.42%. Sales dropped to $189.88 million, a 10.66% decrease between quarters.

Benzinga

Conifer Holdings's Return On Capital Employed Overview

Benzinga Pro data, Conifer Holdings (NASDAQ:CNFR) reported Q1 sales of $23.95 million. Earnings fell to a loss of $2.87 million, resulting in a 258.3% decrease from last quarter.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Chicken Soup for the Soul Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Chicken Soup for the Soul's (NASDAQ:CSSE) reported sales totaled $29.21 million. Despite a 41.27% increase in earnings, the company posted a loss of $11.88 million.

Benzinga

Amtech Systems Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q2, Amtech Systems (NASDAQ:ASYS) earned $1.97 million, a 97.09% increase from the preceding quarter. Amtech Systems also posted a total of $28.58 million in sales, a 4.57% increase since Q1.

Benzinga

Looking Into AgroFresh Solutions's Return On Capital Employed

Benzinga Pro data, AgroFresh Solutions (NASDAQ:AGFS) reported Q1 sales of $39.89 million. Earnings fell to a loss of $3.17 million, resulting in a 243.91% decrease from last quarter.

Benzinga

Coherent's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Coherent (NASDAQ:COHR) posted Q2 earnings of $33.68 million, an increase from Q1 of 11.27%. Sales dropped to $370.20 million, a 3.72% decrease between quarters.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Wendy's's Return on Invested Capital Overview

Pulled from Benzinga Pro data, Wendy's (NASDAQ:WEN) showed a loss in earnings since Q4, totaling $37.40 million. Sales, on the other hand, increased by 3.26% to $488.64 million during Q1.

Benzinga

Avidity Biosciences Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Avidity Biosciences's (NASDAQ:RNA) reported sales totaled $1.79 million. Despite a 11.17% increase in earnings, the company posted a loss of $34.23 million.

Benzinga

Organogenesis Holdings's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Organogenesis Holdings (NASDAQ:ORGO) posted Q1 earnings of $87.00 thousand, an increase from Q4 of 99.83%. Sales dropped to $98.12 million, a 23.68% decrease between quarters.

Benzinga

Talis Biomedical Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Talis Biomedical (NASDAQ:TLIS) reported Q1 sales of $3.19 million. Earnings fell to a loss of $33.05 million, resulting in a 15.35% decrease from last quarter.

Benzinga

SeaChange Shares Plunge On Termination Of Deal With Trillerverz

SeaChange International, Inc (NASDAQ:SEAC) and Trillerverz, the AI-powered open garden platform for creators, mutually agreed to terminate their proposed merger signed on December 22, 2021. SeaChange is a leading provider of video delivery, advertising, streaming platforms, and emerging FAST (Free Ad-Supported Streaming TV services) development. It is no longer possible to complete the…

Benzinga

Cue Biopharma's Return On Capital Employed Overview

Benzinga Pro data, Cue Biopharma (NASDAQ:CUE) reported Q1 sales of $1.00 million. Earnings fell to a loss of $14.26 million, resulting in a 70.02% decrease from last quarter.

Benzinga

10 Analysts Have This to Say About Robinhood Markets

Within the last quarter, Robinhood Markets (NASDAQ:HOOD) has observed the following analyst ratings:

1 … 397 398 399 400

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Brain

12,346 stories

Read news from The Economist, FT, and more,
with one subscription

Places

United States

363,374 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.